IRCCS Fondazione Don Carlo Gnocchi ONLUS, Via Capecelatro 66, Milan, Italy.
IRCCS Fondazione Don Carlo Gnocchi ONLUS, Via Capecelatro 66, Milan, Italy.
Adv Drug Deliv Rev. 2021 Jul;174:229-249. doi: 10.1016/j.addr.2021.04.014. Epub 2021 Apr 19.
Extracellular Vesicles (EVs) are versatile carriers for biomarkers involved in the pathogenesis of multiple human disorders. Despite the increasing scientific and commercial interest in EV application in diagnostics, traditional biomolecular techniques usually require consistent sample amount, rely on operator-dependent and time- consuming procedures and cannot cope with the nano-size range of EVs, limiting both sensitivity and reproducibility of results. The application of biophotonics, i.e. light-based methods, for the diagnostic detection of EVs has brought to the development of innovative platforms with excellent sensitivity. In this review, we propose an overview of the most promising and emerging technologies used in the field of EV-related biomarker discovery. When tested on clinical samples, the reported biophotonic approaches in most cases have managed to discriminate between nanovesicles and contaminants, achieved much higher resolution compared to traditional procedures, and reached moderate to excellent diagnostic accuracy, thus demonstrating great potentialities for their clinical translation.
细胞外囊泡 (EVs) 是多种人类疾病发病机制中涉及的生物标志物的多功能载体。尽管 EV 在诊断中的应用引起了科学界和商业界越来越多的兴趣,但传统的生物分子技术通常需要一致的样本量,依赖于操作人员且耗时,并且无法应对 EV 的纳米尺寸范围,从而限制了结果的灵敏度和重现性。生物光子学(即基于光的方法)在 EV 诊断检测中的应用带来了具有出色灵敏度的创新平台的发展。在这篇综述中,我们提出了对 EV 相关生物标志物发现领域中最有前途和新兴技术的概述。在对临床样本进行测试时,所报道的生物光子方法在大多数情况下成功地区分了纳米囊泡和污染物,与传统方法相比实现了更高的分辨率,并达到了中等至优异的诊断准确性,因此为其临床转化展示了巨大的潜力。